e-learning
resources
European Respiratory Review
2019
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Severe T2-high asthma in the biologics era: European experts' opinion
Ian Pavord, Thomas Bahmer, Fulvio Braido, Borja G. Cosío, Marc Humbert, Marco Idzko, Lukasz Adamek
Source:
Eur Respir Rev, 28 (152) 190054; 10.1183/16000617.0054-2019
Journal Issue:
June
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Ian Pavord, Thomas Bahmer, Fulvio Braido, Borja G. Cosío, Marc Humbert, Marco Idzko, Lukasz Adamek. Severe T2-high asthma in the biologics era: European experts' opinion. Eur Respir Rev, 28 (152) 190054; 10.1183/16000617.0054-2019
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Late Breaking Abstract - Pharmacological and clinical management of severe asthma in 9 countries: An international survey of clinicians.
Source: Virtual Congress 2020 – Advances in asthma treatment
Year: 2020
Research priorities in bronchiectasis: A consensus from the European multicentre bronchiectasis audit and research collaboration (EMBARC) study group
Source: International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives
Year: 2015
Characterising asthma therapy in Scotland: Are the guidelines confusing?
Source: Annual Congress 2012 - Healthcare utilisation and treatment of asthma and COPD
Year: 2012
Implementation of personalized treatment of asthma by improved phenotyping: Critical review of knowledge gaps and unmet research needs by the European asthma research & innovation partnership (EARIP) expert panel
Source: International Congress 2016 – Phenotyping asthma
Year: 2016
A survey of specialist opinions on biomarker use in severe asthma in Australia: scepticism but hope?
Source: ERJ Open Res, 6 (2) 00113-2020; 10.1183/23120541.00113-2020
Year: 2020
International perspectives on severe asthma: Current and future challenges in patient care
Source: International Congress 2016 – Asthma points to ponder
Year: 2016
Patients' perspective on pulmonary rehabilitation: experiences of European and American individuals with chronic respiratory diseases
Source: ERJ Open Res, 4 (4) 00085-2018; 10.1183/23120541.00085-2018
Year: 2018
Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey
Source: Eur Respir J 2002; 20: 799-805
Year: 2002
E-learning course on COPD prevention for Russian GP: what do the doctors say?
Source: Annual Congress 2007 - Smoking and the lung
Year: 2007
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions
Source: Guideline 2019
Year: 2019
Urging Europe to put non-adherence to inhaled respiratory medication higher on the policy agenda: a report from the First European Congress on Adherence to Therapy
Source: Eur Respir J, 49 (5) 1700076; 10.1183/13993003.00076-2017
Year: 2017
Patient concerns regarding asthma, COPD and regular therapies: Results from a European survey
Source: Annual Congress 2010 - Treatment options for asthma
Year: 2010
Prevalence of asthma and management of exacerbations in general practice (GP) after computerised Spanish guideline on the management of asthma (GEMA) and collaborative care environment
Source: International Congress 2015 – Management of asthma and COPD in primary care
Year: 2015
What are common COPD symptoms in a real-life setting? The German DACCORD registry
Source: International Congress 2014 – COPD markers
Year: 2014
Provision of nonpharmacolocical treatment options for COPD patients in 13 European countries: Results from the European COPD audit
Source: Annual Congress 2011 - COPD: integrated care and rehabilitation
Year: 2011
Awareness of GPs in Ukraine in Ukrainian guidelines in diagnostic and treatment of COPD: realities and reasons
Source: Eur Respir J 2004; 24: Suppl. 48, 84s
Year: 2004
If the global initiative for asthma (GINA) reflected on the asthma therapy in Croatia?
Source: Eur Respir J 2001; 18: Suppl. 33, 46s
Year: 2001
The disease burden of mild asthma: Findings from a 2013 real world survey
Source: International Congress 2016 – Asthma and allergy in infancy: from risk factors to mortality
Year: 2016
FASE-CPHG study: a panoramic snapshot of difficult-to-treat, severe asthma in French nonacademic hospitals
Source: ERJ Open Res, 5 (4) 00069-2019; 10.1183/23120541.00069-2019
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept